Business
Bunge is a global agribusiness company that buys, stores, transports, processes, sells, and distributes agricultural commodities and related products. It connects farmers to food, feed, and fuel markets across more than 50 countries.
Bunge grew revenue after Viterra, but profit fell, free cash flow turned negative, and leverage stepped up.
The read at a glance✓ Audited against SEC data
- Growth — Revenue +9.0% to $16.94BOK
- Profitability — Net income -28.2% to $0.82BWatch
- Cash quality — FCF -267.7% to -$0.88BWatch
- Margins — Net margin -249 bpsWatch
- Capital — Buybacks -49.9%; debt +89.6%Watch
- Insiders — 1 open-market buy / 2 sellsNote
Where the revenue comes from
Fiscal 2025, as Bunge Global SA reports it. History and quarterly detail are in the app.
- Soybean Processing and Refining$36.3B
- Grain Merchandising and Milling$18.1B
- Softseed Processing and Refining$11.3B
- Other Oilseeds Processing and Refining$4.6B
Leadership changes
From Bunge Global SA's own filings, the day they're filed.
- Julio Garros · Chief Operating Officer · appointmenteff. 2025-12-12
- David Mattiske · Chief Operating Officer · departureeff. 2025-12-11
- Adrian Isman · directors · appointment
Latest filings
- 8-K · Company announcement2026-09-03
- 8-K · Company announcement2026-08-19
- 10-Q · Quarterly report2026-07-29
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-05-22
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Bunge Global SA, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.